| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer E Kapiteijn, CAM Marijnen, ID Nagtegaal, H Putter, WH Steup, T Wiggers, ... New England Journal of Medicine 345 (9), 638-646, 2001 | 5416 | 2001 |
| Persistent epigenetic differences associated with prenatal exposure to famine in humans BT Heijmans, EW Tobi, AD Stein, H Putter, GJ Blauw, ES Susser, ... Proceedings of the National Academy of Sciences 105 (44), 17046-17049, 2008 | 3718 | 2008 |
| Tutorial in biostatistics: competing risks and multi‐state models H Putter, M Fiocco, RB Geskus Statistics in medicine 26 (11), 2389-2430, 2007 | 2686 | 2007 |
| Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial I Songun, H Putter, EMK Kranenbarg, M Sasako, CJH van de Velde The lancet oncology 11 (5), 439-449, 2010 | 2179 | 2010 |
| Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial W van Gijn, CAM Marijnen, ID Nagtegaal, EMK Kranenbarg, H Putter, ... The lancet oncology 12 (6), 575-582, 2011 | 2130 | 2011 |
| The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma KCMJ Peeters, CAM Marijnen, ID Nagtegaal, EK Kranenbarg, H Putter, ... Annals of surgery 246 (5), 693-701, 2007 | 1520 | 2007 |
| Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority … RA Nout, V Smit, H Putter, IM Juergenliemk-Schulz, JJ Jobsen, L Lutgens, ... The Lancet 375 (9717), 816-823, 2010 | 1373 | 2010 |
| DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific EW Tobi, LH Lumey, RP Talens, D Kremer, H Putter, AD Stein, ... Human molecular genetics 18 (21), 4046-4053, 2009 | 1371 | 2009 |
| Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in … RR Bahadoer, EA Dijkstra, B van Etten, CAM Marijnen, H Putter, ... The Lancet Oncology 22 (1), 29-42, 2021 | 1323 | 2021 |
| Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial HH Hartgrink, CJH Van de Velde, H Putter, JJ Bonenkamp, ... Journal of Clinical Oncology 22 (11), 2069-2077, 2004 | 1265 | 2004 |
| Competing risks in epidemiology: possibilities and pitfalls PK Andersen, RB Geskus, T de Witte, H Putter International journal of epidemiology 41 (3), 861-870, 2012 | 1057 | 2012 |
| Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer—combined analysis of the PORTEC cohorts E Stelloo, RA Nout, EM Osse, IJ Jürgenliemk-Schulz, JJ Jobsen, ... Clinical cancer research 22 (16), 4215-4224, 2016 | 789 | 2016 |
| Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial CAM Marijnen, CJH Van De Velde, H Putter, M Van Den Brink, CP Maas, ... Journal of clinical oncology 23 (9), 1847-1858, 2005 | 765 | 2005 |
| DNA methylation signatures link prenatal famine exposure to growth and metabolism EW Tobi, JJ Goeman, R Monajemi, H Gu, H Putter, Y Zhang, RC Slieker, ... Nature communications 5 (1), 5592, 2014 | 660 | 2014 |
| Right ventricular dysfunction and pulmonary obstruction index at helical CT: prediction of clinical outcome during 3-month follow-up in patients with acute pulmonary embolism RW van der Meer, PMT Pattynama, MJL van Strijen, ... Radiology 235 (3), 798-803, 2005 | 657 | 2005 |
| The bootstrap: a tutorial R Wehrens, H Putter, LMC Buydens Chemometrics and intelligent laboratory systems 54 (1), 35-52, 2000 | 656 | 2000 |
| Randomized feeding intervention in infants at high risk for celiac disease SL Vriezinga, R Auricchio, E Bravi, G Castillejo, A Chmielewska, ... New England Journal of Medicine 371 (14), 1304-1315, 2014 | 655 | 2014 |
| Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy A León-Castillo, SM De Boer, ME Powell, LR Mileshkin, HJ Mackay, ... Journal of Clinical Oncology 38 (29), 3388-3397, 2020 | 652 | 2020 |
| Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data AJ Breugom, M Swets, JF Bosset, L Collette, A Sainato, L Cionini, ... The lancet oncology 16 (2), 200-207, 2015 | 650 | 2015 |
| Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre … SM De Boer, ME Powell, L Mileshkin, D Katsaros, P Bessette, ... The lancet oncology 19 (3), 295-309, 2018 | 637 | 2018 |
Gerrit Jan LiefersUnversity of Leidenยืนยันอีเมลแล้วที่ lumc.nl
